M&T Bank Corp Buys 1,355 Shares of McKesson Corporation $MCK

Key Points

• M&T Bank Corp increased its stake in McKesson by 5.9% in Q4, purchasing 1,355 shares to hold 24,346 shares worth about $19.97 million.
• McKesson beat expectations for the quarter with EPS of $9.34 (vs. $9.19 est.) and revenue of $106.16 billion (+11.4% YoY), and set FY2026 guidance at 38.80–39.20 EPS (consensus ~39.02).
• The company announced a quarterly dividend of $0.82 (annualized $3.28, yield ~0.4%), while insiders sold roughly 3,592 shares (~$3.52M) and institutional investors own about 85.07% of the stock.

M&T Bank Corp raised its stake in shares of McKesson Corporation (NYSE:MCK - Free Report) by 5.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 24,346 shares of the company's stock after purchasing an additional 1,355 shares during the period. M&T Bank Corp's holdings in McKesson were worth $19,971,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also modified their holdings of the stock. J.W. Cole Advisors Inc. grew its position in McKesson by 35.3% during the 3rd quarter. J.W. Cole Advisors Inc. now owns 5,089 shares of the company's stock worth $3,931,000 after purchasing an additional 1,329 shares in the last quarter. Cullen Investment Group LTD. lifted its holdings in shares of McKesson by 550.4% in the fourth quarter. Cullen Investment Group LTD. now owns 4,670 shares of the company's stock valued at $3,811,000 after purchasing an additional 3,952 shares in the last quarter. Private Wealth Partners LLC boosted its position in shares of McKesson by 5.6% in the third quarter. Private Wealth Partners LLC now owns 31,841 shares of the company's stock worth $24,598,000 after buying an additional 1,682 shares during the period. AlphaQuest LLC boosted its position in shares of McKesson by 91.2% in the third quarter. AlphaQuest LLC now owns 1,767 shares of the company's stock worth $1,365,000 after buying an additional 843 shares during the period. Finally, Envestnet Asset Management Inc. grew its holdings in shares of McKesson by 12.4% during the third quarter. Envestnet Asset Management Inc. now owns 330,647 shares of the company's stock valued at $255,438,000 after buying an additional 36,451 shares in the last quarter. 85.07% of the stock is owned by institutional investors.

McKesson Trading Down 0.7%

Shares of NYSE:MCK opened at $808.15 on Tuesday. The firm has a market cap of $98.99 billion, a price-to-earnings ratio of 23.24, a P/E/G ratio of 1.18 and a beta of 0.35. McKesson Corporation has a 1 year low of $637.00 and a 1 year high of $999.00. The business has a fifty day simple moving average of $894.86 and a 200 day simple moving average of $860.34.

McKesson (NYSE:MCK - Get Free Report) last issued its earnings results on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, beating analysts' consensus estimates of $9.19 by $0.15. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The firm had revenue of $106.16 billion for the quarter, compared to the consensus estimate of $105.98 billion. During the same quarter in the previous year, the company posted $8.03 earnings per share. The business's quarterly revenue was up 11.4% compared to the same quarter last year. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, sell-side analysts forecast that McKesson Corporation will post 39.02 EPS for the current year.

McKesson Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 1st. Investors of record on Monday, June 1st will be issued a $0.82 dividend. The ex-dividend date is Monday, June 1st. This represents a $3.28 dividend on an annualized basis and a yield of 0.4%. McKesson's dividend payout ratio is currently 9.43%.

Analyst Ratings Changes

Several research analysts recently weighed in on the company. UBS Group dropped their price target on McKesson from $1,012.00 to $1,000.00 and set a "buy" rating on the stock in a research report on Wednesday, April 22nd. Leerink Partners reaffirmed an "outperform" rating and set a $1,085.00 target price on shares of McKesson in a research note on Thursday, March 5th. Weiss Ratings downgraded McKesson from a "buy (a-)" rating to a "buy (b+)" rating in a report on Thursday, February 5th. JPMorgan Chase & Co. increased their price target on shares of McKesson from $983.00 to $1,107.00 and gave the stock an "overweight" rating in a research report on Tuesday, February 10th. Finally, Morgan Stanley restated an "overweight" rating and set a $966.00 price target on shares of McKesson in a report on Thursday, January 29th. Fourteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $972.27.

Insider Transactions at McKesson

In other news, EVP Michele Lau sold 2,725 shares of the firm's stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $990.00, for a total transaction of $2,697,750.00. Following the transaction, the executive vice president owned 3,247 shares in the company, valued at approximately $3,214,530. This trade represents a 45.63% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the company's stock in a transaction on Friday, February 6th. The stock was sold at an average price of $955.00, for a total transaction of $313,240.00. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 3,592 shares of company stock worth $3,518,555. Corporate insiders own 0.08% of the company's stock.

McKesson Profile

McKesson Corporation NYSE: MCK is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.